Sandbox:Hannan1: Difference between revisions
Jump to navigation
Jump to search
Hannan Javed (talk | contribs) No edit summary |
Hannan Javed (talk | contribs) No edit summary |
||
| Line 10: | Line 10: | ||
!<small>Symptoms</small> | !<small>Symptoms</small> | ||
!<small>Signs</small> | !<small>Signs</small> | ||
!<small>Blood</small> | !<small>Blood & Urine</small> | ||
!<small>Gross</small> | !<small>Gross</small> | ||
!<small>Histology</small> | !<small>Histology</small> | ||
| Line 90: | Line 90: | ||
* Psychosis | * Psychosis | ||
| | | | ||
* ↑ Plasma and urine catecholamines | |||
* ↑ Plasma and urine metanephrines | |||
* ↑ Chromogranin A | |||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
* Heterogeneous appearance, often with some cystic areas. Calcifications or hemorrhage may also be present (CT) | |||
* T2-bright lesions, with/without cystic or necrotic components (MRI) | |||
* Cystic or solid with necrotic areas or hemorrhages (U/S) | |||
| | | | ||
| | | | ||
Revision as of 16:34, 22 January 2019
| Neuroendocrine tumor | Clinical manifestations | Dianosis | Gold
standard |
Other features | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Symptoms | Signs | Blood & Urine | Gross | Histology | Immunohistochemistry | Imaging | Others | ||||
| Medullary thyroid carcinoma[1][2][3] |
|
|
|
|
|
|
|
|
chemistry and calcitonin levels |
| |
| Pheochromocytoma |
|
|
|
|
|||||||
| Merkel cell carcinoma | |||||||||||
| Parathyroid adenoma | |||||||||||
| Paraganglioma | |||||||||||
| Pituitary gland tumors | |||||||||||
| Neuroendocrine tumors of the ovaries or testicles | |||||||||||
| Thymic neuroendocrine cancer | |||||||||||
| Lung neuroendocrine tumors | Typical carcinoid tumours | ||||||||||
| Atypical carcinoid tumours | |||||||||||
| Large cell lung neuroendocrine carcinomas | |||||||||||
| Small cell lung neuroendocrine carcinomas | |||||||||||
| Pancreatic neuroendocrine tumours | Gastrinoma | ||||||||||
| Insulinoma | |||||||||||
| Glucagonoma | |||||||||||
| Somatostatinoma | |||||||||||
| VIPoma | |||||||||||
| ACTHoma | |||||||||||
| Gastric neuroendocrine tumors | Type I GNET | ||||||||||
| Type II GNET | |||||||||||
| Type III GNET | |||||||||||
| Type IV GNET | |||||||||||
| Duodenal neuroendocrine tumors | Gastrinomas | ||||||||||
| Somatostatinomas | |||||||||||
| Gangliocytic paraganglionomas | |||||||||||
| Nonfunctioning NET | |||||||||||
| neuroendocrine carcinomas | |||||||||||
| Jejuno-Ileal neuroendocrine tumors | |||||||||||
| Appendix neuroendocrine tumors | |||||||||||
| Colon neuroendocrine tumors | |||||||||||
| Rectum neuroendocrine tumors | |||||||||||
References
- ↑ Segura S, Ramos-Rivera G, Suhrland M (2018). "Educational Case: Endocrine Neoplasm: Medullary Thyroid Carcinoma". Acad Pathol. 5: 2374289518775722. doi:10.1177/2374289518775722. PMC 6024338. PMID 29978018.
- ↑ Roy M, Chen H, Sippel RS (2013). "Current understanding and management of medullary thyroid cancer". Oncologist. 18 (10): 1093–100. doi:10.1634/theoncologist.2013-0053. PMC 3805151. PMID 24037980.
- ↑ Chen H, Sippel RS, O'Dorisio MS, Vinik AI, Lloyd RV, Pacak K (August 2010). "The North American Neuroendocrine Tumor Society consensus guideline for the diagnosis and management of neuroendocrine tumors: pheochromocytoma, paraganglioma, and medullary thyroid cancer". Pancreas. 39 (6): 775–83. doi:10.1097/MPA.0b013e3181ebb4f0. PMC 3419007. PMID 20664475.